Transcatheter aortic valve replacement: Past, present, and future
Clinical Cardiology · 2024-01 · 47 (1)
DOI: 10.1002/clc.24209 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Cardiology, online erschienen am 14.01.2024. Verfasst von Akash Srinivasan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Sciences, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Transcatheter aortic valve replacement (TAVR) has emerged as a ground‐breaking, minimally invasive alternative to traditional open‐heart surgery, primarily designed for elderly patients initially considered unsuitable for surgical intervention due to severe aortic stenosis. As a result of successful large‐scale trials, TAVR is now being routinely applied to a broader spectrum of patients. In deciding between TAVR and surgical aortic valve replacement, clinicians evaluate various factors, including patient suitability and anatomy through preprocedural imaging, which guides prosthetic valve sizing and access site selection. Patient surgical risk is a pivotal consideration, with a multidisciplinary team making the ultimate decision in the patient's best interest. Periprocedural imaging aids real‐time visualization but is influenced by anaesthesia choices. A comprehensive postprocedural assessment is critical due to potential TAVR‐related complications. Numerous trials have demonstrated that TAVR matches or surpasses surgery for patients with diverse surgical risk profiles, ranging from extreme to low risk. However, long‐term follow‐up data, particularly in low‐risk cases, remains limited, and the applicability of published results to younger patients is uncertain. This review delves into key TAVR studies, pinpointing areas for potential improvement while delving into the future of this innovative procedure. Furthermore, it explores the expanding role of TAVR technology in addressing other heart valve replacement procedures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Sciences, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
- Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.
ORCID-Profile: Brian Wang
Zitieren
APA
Srinivasan, A., Wong, F., & Wang, B. (2024). Transcatheter aortic valve replacement: Past, present, and future. Clinical Cardiology, 47(1). https://doi.org/10.1002/clc.24209
Vancouver
Srinivasan A, Wong F, Wang B. Transcatheter aortic valve replacement: Past, present, and future. Clinical Cardiology. 2024;47(1). doi:10.1002/clc.24209
BibTeX
@article{Srinivasan2024,
author = {Srinivasan, Akash and Wong, Felyx and Wang, Brian},
title = {Transcatheter aortic valve replacement: Past, present, and future},
journal = {Clinical Cardiology},
year = {2024},
volume = {47},
number = {1},
doi = {10.1002/clc.24209}
}
EUVIMED